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Abstract
Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by acute
lung inflammation. Intercellular adhesion molecule-1 (ICAM-1) and interleukin-8 (IL-8) play an important role in the
development of these diseases. Mitogen-activated protein kinase (MAPK) p38/activated protein kinase 2 (MK2)
regulates the expression of ICAM-1 and IL-8 in human lung microvascular endothelial cells (HPMECs) stimulated by
tumor necrosis factor-α (TNF-α); however, the underlying molecular mechanism remains unclear. Here, we show
that human antigen R (HuR), an RNA binding protein which binds preferentially to AU-rich elements (AREs) and
stabilizes mRNAs, regulates TNF-α-induced ICAM-1 expression in the MK2/HuR signaling pathway.
Method: MK2 and HuR were silenced respectively in HPMECs and then HPMECs were stimulatied with TNF-α.
Nucleo-cytoplasmic shuttling of HuR was detected by subcellular fractionation and confocal microscopy in
MK2 knockdown HPMECs. In HuR silencing cells, protein and mRNA levels of ICAM-1 and IL-8 were measured
by western blot analysis, ELISA and real-time PCR; mRNA stabilization were measured by real-time PCR after
actinomycin D (ActD) blocking transcription. Furthermore, we performed neutrophil adhesion assay to assess
the adhering capacity after HuR silencing.
Results: MK2 were subjected to a knockdown by interfering RNA, the mRNA and protein levels of HuR in human
pulmonary microvascular endothelial cells (HPMECs) were not affected. However, after the stimulation of TNF-α, silencing
MK2 inhibited HuR accumulation to cytoplasm from nucleus in HPMECs. Consequently, knockdown of HuR by RNA
interference in HPMECs, there was reduction in the stability of ICAM-1 mRNA and ICAM-1 protein level. This event was
accompanied by a decrease in the adhesion of neutrophils towards HPMECs. Nevertheless, HuR silencing had no effect
on the mRNA and protein levels of IL-8.
Conclusion: These results indicate that MK2 post-transcriptionally regulates TNF-α-induced ICAM-1 expression by
altering the cytoplasmic localization of HuR in HPMECs.
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Background
Acute lung injury (ALI) and acute respiratory distress syn-
drome (ARDS) are two acute inflammatory diseases. In the
lungs, neutrophil recruitment and activation play a pivotal
role in ALI/ARDS [1, 2]. Tumor necrosis factor-α (TNF-α),
an important proinflammatory factor of ALI/ARDS [3],
stimulates the expression of intercellular adhesion mol-
ecule-1 (ICAM-1) and interleukin-8 (IL-8) in human pul-
monary microvascular endothelial cells (HPMECs) [4–6].
Both ICAM-1 and IL-8 are the most important inflamma-
tory mediators that are responsible for the migration, re-
cruitment, and infiltration of neutrophil that are produced
to combat acute lung inflammation in humans [7, 8]. Our
previous study showed that mitogen-activated protein kinase
(MAPK) p38/ MAPK-activated protein kinase 2 (MK2)
regulates the expression of ICAM-1 and IL-8 at the post-
transcriptional level in HPMECs after TNF-α stimulation
[4]. However, the precise mechanism by which MK2 regu-
lates ICAM-1 and IL-8 expression remains elusive.
Previous studies have shown that the stability of
mRNA containing AU-rich elements (ARE)(AU is the
abbreviated form of adenylate uridylate) is regulated
through an MK2-dependent and ARE-targeted mechan-
ism [9–11]. Moreover, MK2 plays an important role in
regulating the expression of TNF-α and IL-6 [11–13].
However, the downstream proteins by which MK2 stabi-
lizes ARE-containing mRNAs are largely unknown.
HuR, a member of the embryonic lethal abnormal visual
family, can bind to the ARE motif, such as AUUUA in
the 3′-UTR of mRNA [14–17]. Recent studies have
shown that HuR increases the mRNA stability of sur-
vival motor neuron (SMN) protein and toll-like recep-
tor 4 (TLR4), which are located in motor neuron
derived (MN-1) cells and vascular smooth muscle cells
(VSMCs), respectively [18, 19]. Furthermore, it has
been reported that active MK2 induces cytoplasmic ac-
cumulation of HuR, which correlates with increased
stability of urokinase plasminogen activator (uPA) and
uPA receptor mRNAs that have AREs in their 3′-UTR
[20, 21]. Considering that AREs located in the 3′-UTR
of ICAM-1 and IL-8 mRNAs, we hypothesize that the
MK2 pathway might regulate the expression of ICAM-
1 and IL-8 through HuR in TNF-α-induced HPMECs.
In this study, we have investigated the intracellular
localization of HuR following silencing of MK2 and de-
termined ICAM-1 and IL-8 the expression after knock-
down of HuR in TNF-α stimulated HPMECs. We found
that TNF-α stimulation induced cytoplasmic accumula-
tion of HuR, which was significantly suppressed by
MK2 silencing. Importantly, knockdown of HuR desta-
bilized ICAM-1 mRNA and reduced ICAM-1 protein
levels. Our study revealed that MK2 mediates expres-
sion of ICAM-1 with TNF-α stimulation by increasing
the cytoplasmic accumulation of HuR in HPMECs.
Methods
Materials
Actinomycin D (ActD) was purchased from Sigma-Aldrich
(St. Louis, USA). Lipofectamine 2000 (11668–027) and
Opti-MEM I reduced serum medium were obtained from
Invitrogen (Carlsbad, USA). MK2 siRNA, HuR siRNA and
negative control siRNA were received from GenePharma
(Shanghai, China). TNF-α (300-01A) was purchased from
PeproTech (Rocky Hill, USA). Phosphatase Inhibitor
Cocktail (04906845001) was from Roche (Mannheim,
Germany). An enhanced chemiluminescent (ECL) kit were
obtained from Pierce (Rockford, USA). The protein assay
kit, nuclear and cytoplasmic protein extraction kit (P0027)
and the RIPA Lysis Buffer (P0013C) were purchased from
Beyotime Institute of Biotechnology (Nantong, China).
Antibodies raised against MK2 (#3042), phospho-MK2
(Thr334, #3041), ICAM-1 (#4915) was obtained from Cell
Signaling (Danvers, USA); a monoclonal antibody against
HuR (ab14371) was received from Abcam (Cambridge,
USA); antibodies against β-actin (P30002) and histone
(P30266) were from Abmart (Shanghai, China);IL-8 ELISA
Kit (BMS204/3) was received from eBioscience (San Diego,
USA). RevertAid First Strand cDNA Synthesis Kit
(#K1622) was purchased from Fermentas UAB (Vilnius,
Lithuania). FastStart Universal SYBR Green Master (Rox)
(04913914001) was purchased from Roche (Mannheim,
Germany). Endothelial cell medium and HPMECs were
purchased from ScienCell (Carlsbad, USA).
Cell culture, treatment, and transfection
HPMECs were grown in ECM medium supplemented
with 5 % fetal bovine serum.MK2 siRNA and HuR
siRNA were respectively reverse transfected at a concen-
tration of 40 nm with Lipofectamine 2000 diluted in
Opti-MEM. After 24 h, to allow for gene silencing, cells
were stimulated with TNF-α. The final concentration of
TNF-αwas 10 ng/ml. The sequences of siRNAs are as
follows: MK2 siRNA 1: sense (5’-GAC CAG GCAUUC
ACA GAA ATT-3’) and antisense (5’-UUU CUG UGA
AUG CCU GGU CTT-3’); MK2 siRNA 2: sense (5’-CAC
CCU UGG AUC AUG CAA UTT-3’) and antisense (5’-
AUU GCA UGA UCC AAG GGU GTT-3’); MK2 siRNA
3: sense (5’- GUU AUA CAC CGU ACU AUG UUU-3’)
and antisense (5’-ACA UAG UAC GGU GUA UAA
CUU-3’); HuR siRNA: sense (5’-GGA UGA GUU ACG
AAG CCU GTT-3’) and antisense (5’-CAG GCU UCG
UAA CUC AUC CTG-3’). Controls were treated with
negative control siRNA anLipofectamine 2000.
Western blot
The total cellular lysates were prepared as previously de-
scribed [22]. Cells were lysed with RIPA lysis buffer con-
taining proteinase inhibitor. Cell lysates were mixed with
loading buffer and boiled for 10 min, resolved by 10 %
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sodium dodecyl sulfatepolyacrylamide gel electrophoresis,
and transferred onto a polyvinylidene fluoride membrane
(PVDF). The membranes were blocked with 5 % bovine
serum albumin (BSA). Western blot analysis was then per-
formed in accordance with standard protocols using anti-
bodies against MK2,HuR,ICAM-1, β-actin and histone,
followed by incubation with relevant horseradish peroxi-
daseconjugated (HRP) secondary antibodies. The immune
complexes were visualized on FluorChem FC2 system
(Cell Biosciences, Santa Clara, USA). Densitometric ana-
lysis of bands was performed by ImageJ software (http://
rsb.info.nih.gov/ij/, National Institutes of Health, USA),
and the data were normalized to β-actin or histone.
Subcellular fractionation
The Nuclear and Cytoplasmic Protein Extraction Kit
(P0027) were purchased from Beyotime Institute of
Biotechnology (Nantong, China). Nuclear and cytoplas-
mic protein fractions of HPMEC were obtained accord-
ing to manufacturer’s directions. In brief, extraction
reagent A for cytoplasmic protein was added with 1 mM
phenylmethylsulfonyl fluoride (PMSF) and incubation on
ice for 15 min. Then extraction reagent B for cytoplas-
mic protein was added. The cytosolic fractions were pre-
pared by high-speed centrifugation (16000 g for 5 min at
4 °C) and the supernatant was collected. For preparing
nuclear fractions, extraction reagent for nuclear protein
with PMSF in supplemented was added to nuclear sedi-
ment, centrifuged (10 min, 16000 g, 4 °C) after 30 min,
and the supernatant was saved.
Confocal microscopy
HPMECs seeded on coverslips were transfected with
siRNA or negative control siRNA as described above.
After treatment with TNF-α, cells were washed using
with phosphate buffered saline (PBS) and fixed with 4 %
paraformaldehyde for 15 min at room temperature. The
fixed HPMECs were permeabilized with 0.5 % Triton X-
100 in PBS for 10 min at room temperature. Subse-
quently, they were blocked with 1 % BSA in PBST for
30 min at room temperature. Finally, they were washed
with PBS and incubated overnight with primary HuR anti-
body (100-fold diluted with 1 % BSA in PBST) at 4 °C,
followed by 3 × 5 min washes with PBS. The HPMECs
were then incubated with fluorescein isothiocyanate
(FITC)-labeled goat anti-mouse IgG (green) (200-fold
diluted with 1 % BSA in PBST) for 1 h in the dark. Follow-
ing 3 × 5 min washes with PBS, the 4’-6-diamidino-2-phe-
nylindole (DAPI) was used to stain the cell nuclei (blue)
for 5 min at a concentration of 1 μg/ml. After 3 × 5 min
washes with PBS, the confocal images were acquired using
an Olympus FV1000 confocal microscope (Olympus,
Tokyo, Japan). FV10-ASW software (Olympus Europa,
Japan) was used to process the images.
Enzyme-linked immunosorbent assay (ELISA)
Cell-free supernatants were saved and aliquots were
stored at −70 °C until use. The protein levels of IL-8 in
medium were measured with commercially available
cytokine specific ELISA kits (eBioscience, USA) accord-
ing to the manufacturers’ recommendations.
RNA isolation and Quantitative RT-PCR
Total RNA was isolated from cultured cells by TRIzol
and used in reverse transcription and PCR amplifica-
tion reactions as described [22]. Quantitative RT-PCR
analysis was performed on an Applied Biosystems
model 7300 real-time PCR machine. (Applied Biosys-
tem, Foster City, USA). Data were analyzed by delta-
delta Ct method and normalized to the housekeeping
gene GAPDH. The primers used for the amplifications
are as follows: GAPDH forward, TGCACCACCAACT
GCTTAGC; GAPDH reverse, GGCATGGACTGTGG
TCATGAG; HuR forward, CCGTCACCAATGTGAAA
GTG; HuR reverse, TCGCGGCTTCTTCATAGTTT;
ICAM-1 forward, AGCTTCTCCTGC TCTGCAAC; IC
AM-1 reverse, GTCTGCTGGGAATTTTCTGG; IL-8
forward, ATG ACTTCCAAGCTGGCCGTGGCT; IL-8
reverse, TCTCAGCCCTCTTCAAAAACT TCTC.
Analysis of mRNA stability by real-time PCR
50 % confluent cells were first preincubated with Actino-
mycin D (5 μg/ml) for 2 h; cells were then treated with
TNF-α (10 ng/ml) for 2 h in the presence of actinomycin
D. Total RNA was prepared as described [22]. HuR,
ICAM-1 and IL-8 mRNAs levels were normalized to
GAPDH mRNA. The normalized value at TNF-α 0 h
was set as 100 %. GraphPad Prism software version 5.01
(GraphPad Software,Inc.,USA) was used to calculated
the half-lives of mRNAs on a one-phase exponential
decay model. The semi-logarithmic curves were also
analysis by GraphPad Prism software.
Neutrophil preparation
Neutrophil polymorphonuclear granulocytes (PMN) were
isolated from the peripheral blood of healthy human vol-
unteers from Lianyungang First People’s Hospital using
Ficoll-Hypaque (Sigma, poole, UK) density gradient cen-
trifugation, as previously described [23]. Residual erythro-
cytes were subjected to hypotonic lysis. The remaining
neutrophils were washed and resuspended again in PBS
such that their concentration in the suspension was
5x107cells/ml. We used this neutrophilic suspension in
PBS within 4 h.
Neutrophil adhesion assay
PMN were labeled for 1 h at 37 °C with 10 mM 2',7'-bis-
(2-carboxyethyl)-5-(and-6)-carboxyfluorescein,acetoxy-
methyl ester BCECF/AM (Beyotime, Haimen, China).
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HPMECs were grown in 12-well plates and transfected
with siRNA or negative control siRNA as described
above. After treatment with TNF-α to HPMEC, the
labeled PMN were added to each HPMEC containing
well and incubated for 1 h. Non-adherent PMN were
removed by two gentle washes with PBS; The adhe-
sion PMN cells were counted in five high-power
fields per well under fluorescence microscope (Olym-
pus BX61, Japan) and expressed as adhesion PMN per
high-power fields.
Statistical analysis
Data were expressed as either a representative experi-
ment or the mean ± standard error (SE) of three inde-
pendent experiments. Statistical analysis to determine
significance was calculated using variance (ANOVA)
and an unpaired t test two tailed, analyzing the differ-
ences between the different time points within the
same treatment group and between different groups,
respectively. P values < 0.05 was consideredstatistically
significant. Statistical analysis was performed by SPSS
13.0 (IBM SPSS, Chicago, USA).
Results
Knockdown of MK2 by siRNA had proved to be
inoperative on HuR expression
It was reported that activation of p38 MAPK via IL-1β
and TNF-α is implicated in HuR-mediated stabilization
of mRNAs coding for key inflammatory mediators in-
cluding IL-6, cyclooxygenase-2 (COX-2) and TNF-α
[24]. MK2 has been shown crucial for HuR translocation
[24, 25], but it remains unknown whether MK2 affects
the expression of HuR mRNA and protein after TNF-α
activation. To assess the role of MK2 in HuR expression,
we applied MK2 siRNA (40 nM) to silence MK2, and
then the HPMECs were stimulated with TNF-α (10 ng/
ml). After 0, 1, 2, 4, 8 and 12 h, RNA and protein were
extracted for real-time PCR and immunoblotting. The
Western immunoblot analysis manifest that MK2 knock-
down remarkably weakened MK2 expression level to
~18 % of controls (Fig. 1a). Phosphorylation of MK2 is
essential for MK2 activtion. MK2 siRNA reduced the
phosphorylation MK2 under normal growth condition
(Fig. 1b). TNF-α stimulation for 10 and 30 min obvi-
ously increased the phosphorylation of MK2, which was
apparently reduced by MK2 siRNA (Fig. 1b). Next, we
Fig. 1 The effect of MK2 on TNF-α-induced HuR expression in HPMECs. The Western blot band density data showed that MK2 knockdown greatly
reduced the levels of MK2 (a) and phospho-MK2 (b). MK2 silencing had no effect on HuR mRNA levels (c) and HuR protein levels (d). Band density
and mRNA data are expressed as mean ± SEM. n =3, #P <0.05 vs. negative control siRNA-transfected cells; *P <0.05 vs. cells at TNF-α 0 h. Control
siRNA, negative control siRNA; P-MK2, phospho-MK2
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assessed HuR mRNA expression in HPMECs after TNF-
α stimulation in condition of MK2 knockdown. As
shown in Fig. 1c, HuR mRNA levels did not change sig-
nificantly after TNF-α stimulation both in control
groups and in MK2-silencing groups, a difference that
was not statistically significant. To test whether MK2 in-
fluences HuR protein levels, total cellular proteins were
prepared for immunoblotting of HuR. Silencing of MK2
did not influence HuR protein levels in the presence or
absence of TNF-α stimulation (Fig. 1d), which was con-
sistent with the mRNA results. These results suggest
that MK2 does not control the expression of HuR.
MK2 promotes cytoplasmic accumulation of HuR
It has been observed that the active MK2 can induce
cytoplasmic accumulation of HuR in HeLa cells [20].
Another study in MN-1 cells showed that p38 MAPK
inhibition significantly reduced cytoplasmic accumula-
tion of HuR [18]. Our previous and the present studies
have shown that TNF-α stimulation can activate the p38
MAPK/MK2 cascade (Fig. 1b and reference 3). It is thus
possible that activation of p38 MAPK/MK2 by TNF-α
stimulation may promote the cytoplasmic accumulation
of HuR in HPMECs. To this end, we analyzed the intra-
cellular localization of HuR following MK2 silencing in
the presence or absence of TNF-α. The nuclear HuR
levels did not change significantly after TNF-α stimula-
tion with or without MK2 knockdown (Fig. 2a). In sharp
contrast, TNF-α stimulation significantly elevated the
levels of cytoplasmic HuR, which were markedly re-
duced by MK2 siRNA (Fig. 2b). Further, the immuno-
fluorescent staining for HuR (green) and DAPI (blue)
showed that HuR was mainly accumulated in nucleus
prior to TNF-α stimulation. Cytoplasmic HuR signifi-
cantly increased after 2 h of TNF-α stimulation and then
decreased after 8 h, while there was no remarkable
change in nuclear HuR levels (Fig. 2c). Compared to the
controls, MK2 siRNA reduced cytoplasmic HuR but had
minimal effect on the nuclear HuR levels (Fig. 2c). These
results suggest that MK2 promotes cytoplasmic accumu-
lation of HuR after TNF-α stimulation in HPMECs.
HuR silencing reduces TNF-α-induced expression of ICAM-
1 but not IL-8 release
It has been previously reported that HuR plays an import-
ant role in the post-transcriptional regulation of inflam-
matory factors expression such as vascular endothelial
growth factor (VEGF) and IL-8 in malignant glioma cells
and HCT8 cells, respectively [26, 27]. It is possible that
the attenuation of cytoplasmic accumulation of HuR may
contribute to the downregulation of ICAM-1 and IL-8,
which was caused by TNF-α stimulation in MK2 silencing
HPMECs. To test this hypothesis, we first examined the
effect of HuR knockdown on TNF-α-induced ICAM-1
and IL-8 expression in HPMECs. HuR siRNA were trans-
fected to cells for 24 h, and then cells recovered for an-
other 24 h and stimulated with TNF-α. As shown in
Fig. 3a, HuR siRNA (40 nM) significantly decreased HuR
protein levels to 19 % of controls. TNF-α significantly in-
duced the protein expression of both ICAM-1 (Fig. 3b)
and IL-8 (Fig. 3c). HuR knockdown greatly reduced
ICAM-1 levels compared to controls after TNF-α stimula-
tion (Fig. 3b). In contrast to ICAM-1, the ELISA result
showed HuR silencing had no effect on IL-8 release
(Fig. 3c), which is not consistent with a previous study in
HCT8 cells [26]. These results indicate the implication of
HuR in the regulation of TNF-α-induced ICAM-1 expres-
sion without influencing IL-8 release in HPMECs.
HuR increases the stability of ICAM-1 mRNA but not IL-8
We next investigated whether HuR regulates the
mRNA of ICAM-1 and IL-8. The real-time quantitative
PCR results showed that ICAM-1 mRNA gradually in-
creased and reached summit at 4 h of TNF-α stimula-
tion, then went to baseline after 8 h in negative control
siRNA-transfected cells. In sharp contrast, silencing of
HuR significantly reduced ICAM-1 mRNA levels, and
that was one fifth of controls 4 h after treatment with
TNF-α (Fig. 4a). In control group, IL-8 mRNA in-
creased to the top level at 4 h of TNF-α stimulation,
while there was no significant difference of the IL-8
mRNA levels between control and HuR siRNA trans-
fected cells (Fig. 4b). All datas demonstrated that HuR
knockdown decreased ICAM-1 mRNA but does not in-
fluence IL-8 mRNA in HPMECs after TNF-α stimula-
tion, which is consistent with the ICAM-1 and IL-8
proteins results (Fig. 3).
Subsequently, we explored whether HuR affects
ICAM-1 and IL-8 mRNA stability. TNF-α stimulated
HPMECs which were transfected with HuR or negative
control siRNAs for 2 h, and then Act D (5 μg/ml) was
added to stop gene transcription. After 0, 1, 2, and 4 h,
total cellular RNA was harvested for real-time PCR to
detect ICAM-1 and IL-8 mRNA levels. In control cells,
the half-life of ICAM-1 mRNA after TNF-α stimulation
was 118 min while was significantly reduced to 52 min
in HuR-silenced HPMECs (P <0.05) (Fig. 4c). The half-life
of IL-8 mRNA in control cells and in HuR-silenced
HPMECs was comparable, which was 126 and 114 min,
respectively (P >0.05). These results indicates a TNF-α-
induced, HuR-dependent stabilization of ICAM-1 mRNA
in HPMECs.
HuR knockdown inhibits TNF-α-induced PMN adhesion to
HPMECs
ICAM-1 has been extensively studied from the stand-
point of differentiating ALI from hydrostatic pulmonary
edema and as the biomarker of prognosis of AIL/ARDS.
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Calfee et al. demonstrated that the ICAM-1 levels of
plasma and pulmonary edema fluid are significantly
higher in those with ALI/ARDS [28, 29]. ICAM-1 is
found on the vascular endothelium and lung epithe-
lium, and participates in transmigration of leukocytes
to the site of inflammation [6, 30]. Our observation that
HuR silencing reduced TNF-α-induced expression of
ICMA-1, suggests that HuR may affect the interaction
of neutrophil polymorphonuclear granulocytes (PMN)
with HPMECs. For this, we examined the adhesion of
PMN to TNF-α-activated HPMECs. Control confluent
HPMECs incubated with PMN for 1 h showed minimal
binding, but adhesion was gradually increased when
the HPMECs were pretreated with TNF-a for 6 h,
12 h and 24 h (Fig. 5a and b). However, compared
with TNF-a-treated HPMEC, silenceing of HuR with
siRNA significantly reduced the number of PMN
adhered to TNF-a-stimulated HPMEC (6 h, 12 h,
24 h) by 30 %, 18 % and 20 % inhibition, respectively
(P <0.05) (Fig. 5b and c). These results suggest HuR
promotes the adhesion of of PMN to TNF-α-activated
HPMECs.
Fig. 2 Knockdown of MK2 by inhibited TNF-α induced cytosolic accumulation of HuR. Lysates from control cells and MK2-silenced cells were subject to
Western blot analysis for HuR, the densitometric analysis showed that MK2 silencing did not influence the nuclear HuR levels (a), however, reduced
cytoplasmic accumulation of HuR compared to the control cells (b). The immunofluorescent staining for HuR (green) and DAPI (blue) showed that HuR
was mainly accumulated in nucleus prior to TNF-α stimulation. Cytoplasmic HuR significantly increased after 2 h of TNF-α stimulation and then decreased
after 8 h, while there was no remarkable change in nuclear HuR levels. Compared to the controls, MK2 silencing reduced cytoplasmic HuR but did not
greatly affect the nuclear HuR levels (c). Western blot band density data are expressed as mean ± SEM. n =3, #P <0.05 vs. negative control siRNA-
transfected cells, *P <0.05 vs. cells at TNF-α 0 h. Control siRNA, negative control siRNA N-HuR, nuclear HuR; C-HuR, cytoplasmic HuR
Wu et al. BMC Pulmonary Medicine  (2016) 16:84 Page 6 of 11
Discussion
In this study, we found that knockdown of MK2 by
siRNA did not affect the expression but significantly
impaired the cytoplasmic accumulation of HuR after
TNF-α stimulation in HPMECs. We further revealed
that HuR knockdown decreased the mRNA and protein
levels of ICAM-1 in HPMECs after TNF-α stimulation.
Most importantly, silencing of HuR resulted in
destabilization of the mRNA of ICAM-1 and inhibition of
TNF-α-induced PMN adhesion to HPMECs. Our results
suggest that MK2 regulates TNF-α-induced ICAM-1 ex-
pression by altering the cytoplasmic localization of HuR in
HPMECs.
HuR is a member of the embryonic lethal abnormal vis-
ual family and can bind to the ARE motif such as AUUUA
in the 3′-UTR of mRNAs. The cytoplasmic localization of
HuR increases its binding to the AREs and stabilizes the
ARE-containing mRNAs [26, 27, 31, 32]. Our previous
studies have shown that MK2 up-regulates ICAM-1
and IL-8 expression following TNF-α stimulation in
HPMECs. However, the downstream protein by which
MK2 regulates ICAM-1 and IL-8 expression is un-
known. A previous study has shown that MK2 can pro-
mote cytoplasmic accumulation of HuR in HeLa cells
[20]. To investigate whether MK2/HuR pathway is in-
volved in the regulation of ICAM-1 and IL-8 expression
in HPMECs, we firstly examined the effect of MK2 on
HuR expression. Our study indicates that HuR mRNA
and protein level changed little after TNF-α activation
in presence or absence of MK2 silencing neither, imply-
ing that MK2 is not involved in the regulation of HuR
expression. Further, we found that HuR was mainly
located in nucleus, and there was very little HuR in
cytoplasm before TNF-α activation. TNF-α activation
greatly increased MK2-dependent cytoplasmic accu-
mulation of HuR. These results indicate that the sub-
cellular localization of HuR is regulated by MK2 in
TNF-α-activated HPMECs. It should be noted that
the levels of nuclear HuR did not decrease concomi-
tantly with the increase of cytoplasmic HuR. A possible
explanation is that there is so little HuR in cytoplasm that
small parts of HuR translocated to cytoplasm leads to a
Fig. 3 HuR silencing reduced ICAM-1 levels, while had no effect on IL-8 expression. The Western blot showed that HuR silencing greatly reduced
HuR levels and down-regulated ICAM-1 levels following TNF-α stimulation (a and b). ELISA analysis demonstrated a significant increase of IL-8
both in HuR-silenced cells and control cells after TNF-α stimulation, nevertheless, the IL-8 levels in both groups were statistically undistinguishable
(c). Western blot band density and ELISA data are expressed as mean ± SEM. n =3, #P <0.05 vs. negative control siRNA-transfected cells, *P <0.05
vs. cells at TNF-α 0 h. Control siRNA, negative control siRNA
Wu et al. BMC Pulmonary Medicine  (2016) 16:84 Page 7 of 11
significant increase in cytoplasmic HuR but not detectable
alteration of HuR in nuclei.
HuR has been reported to regulate the expression of
several factors such as VEGF, IL-8 and survivin by
stabilizing these ARE-bearing mRNAs in other cells
[14, 26, 27, 33]. Similar to those results, our present
study showed that HuR silencing reduced the mRNA
stability and protein levels of ICAM-1. However, in
contrast to the previous two studies in malignant glioma
cells and HCT8 cells [26, 27], HuR had no effect on IL-8
expression in TNF-α-stimulated HPMECs. Considering
malignant glioma cells and HCT8 cells are both cancer
cells, we suppose that some factor(s) present in HPMECs
but absent in cancer cells may compensate for the lack of
HuR in regulating IL-8 but not ICAM-1 after TNF-α
stimulation. We further found that the ICAM-1 mRNA in
HuR-silenced cells became less stable and the half-life was
remarkably decreased compared to that in control groups.
Nevertheless, the IL-8 mRNA levels and stability in con-
trol cells and that in HuR-silenced cells were similar.
Taken our previous studies together, we conclude for the
first time that the MK2/HuR pathway is involved in the
regulation of TNF-α-induced ICAM-1 expression by alter-
ing the mRNA stability (Fig. 6).
To date, the exact mechanisms of ALI/ARDS are not
completely known. The present results demonstrated
that knockdown of HuR inhibited neutrophil adherence
to the HPMECs. Our findings suggest that the MK2/
HuR pathway may play an important role in acute in-
flammatory response in HPMECs and may become an
effective treatment target for ALI/ARDS in future.
Although the latest research indicates that the MK2/
HuR pathway regulated ICAM-1 expression after TNF-
α stimulation in HPMECs, the mechanisms by which
MK2 regulates HuR translocation are not completely
understood. Doller et al. [34] have reviewed several sig-
naling pathways regulating nucleo-cytoplasmic shut-
tling of HuR, and pointed out that the protein sequence
of HuR has no putative phosphorylation sites for
MAPKs and HuR may probably not be phosphorylated
by MK2. However, a study in RKO cells showed that
HuR is phosphorylated at Thr118 by p38 MAPK and
the Thr118 phosphorylation contributes to cytosolic
localization of HuR induced by γ radiation [35]. Further
studies are needed to clarify whether MK2 promotes
cytoplasmic localization of HuR by phosphorylating
Thr118 of HuR in TNF-α-stimulated HPMECs. It
should be noted that, in addition to HuR, there are
Fig. 4 HuR affected the levels and stability of ICAM-1 mRNA without influencing IL-8 mRNA in HPMECs. Following TNF-α stimulation, the ICAM-1
and IL-8 mRNA levels were significantly increased in control cells, while HuR knockdown markedly reduced ICAM-1 mRNA levels but not IL-8
mRNA (a and b). HuR silencing decreased ICAM-1 mRNA stability, and the half-life was 118 min and 52 min in control cells and HuR-silenced cells,
respectively (c). The half-life of IL-8 mRNA was 126 min and 114 min in control cells and HuR-silenced cells, respectively (d). Each point represents
the mean ± SEM. n =3, #P <0.05 vs. negative control siRNA-transfected cells, *P <0.05 vs. cells at TNF-α 0 h
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many other ARE-binding proteins such as tristetrapro-
lin [36] and hnRNP A0 [37], it will be of importance to
assess whether other ARE-binding proteins are involved
in the regulation of ICAM-1 and IL-8 expression and
whether other ARE-binding proteins interact with HuR.
Conclusions
In summary, our results showed that the MK2/HuR
signaling axis regulated TNF-α-induced ICAM-1 expres-
sion by promoting the stabilization of ICAM-1 mRNA
in HPMECs, and silencing of HuR impaired TNF-α-
Fig. 6 Schematic model of the MK2/HuR pathway in the post-transcriptional regulation of TNF-α-induced ICAM-1 expression. The present results
show that HuR nucleo-cytoplasmic shuttling mediated by TNF-α stimulation results in the stabilization of ICAM-1 mRNAs and increased protein
production. The possible mechanism is that MK2 induces HuR cytoplasmic translocalization, which leads to an increase in stability of HuR-mRNA
complex formation, and therefore increases ICAM-1 expression. TNFR, TNF-receptor; sICAM-1, soluble ICAM-1
Fig. 5 HuR knockdown inhibited PMN adhesion to TNF-α-induced HPMECs. HuR was silenced with HuR siRNA (40 nM), and then the HPMECs were
stimulated with TNF-α (10 ng/ml) for 0 h, 6 h, 12 h and 24 h. BCECF/AM-labeled (green fluorescence) PMN were seed onto HUVEC and co-cultured for1
h. After removing the non-adherent cells, adherent cells were photographed and analyzed by microscopy. The pictures are representative optical fields
(a) and fluorescence microscope (b) at different treatment (×200). (c) Quantitative analysis of the binding of PMN to HUVEC presented by bar graphs.
Quantitative analysis are expressed as mean ± SEM. n =3, *P <0.05 vs. negative control siRNA-transfected cells. Control siRNA, negative control siRNA
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induced adhesion of neutrophils to HPMECs. Our find-
ings suggest that the MK2/HuR pathway play an import-
ant role in acute inflammatory response in HPMECs and
targeting MK2/HuR signaling is a promising strategy for
the development of an effective treatment for ALI/ARDS.
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